MONT SAINT-HILAIRE, QUEBEC -- (MARKET WIRE) -- September 18, 2006 -- Axcan Pharma Inc. (“Axcan” or the “Company”) (TSX VENTURE: AXP) (Nasdaq:AXCA) today announced that on Thursday, September 21, 2006, President and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will present an overview of the Company at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference to be held in London, United Kingdom. This presentation will take place at 4:40 p.m. BST (11:40 a.m. Eastern time).
